197 related articles for article (PubMed ID: 18504690)
1. [Edema related to treatment with olanzapine].
Wustmann T; Fiedler T; Gutmann P
Psychiatr Prax; 2009 Apr; 36(3):142-4. PubMed ID: 18504690
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
McEvoy JP; Lieberman JA; Perkins DO; Hamer RM; Gu H; Lazarus A; Sweitzer D; Olexy C; Weiden P; Strakowski SD
Am J Psychiatry; 2007 Jul; 164(7):1050-60. PubMed ID: 17606657
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder.
Post DE
Behav Med; 2007; 33(1):11-4. PubMed ID: 17517541
[TBL] [Abstract][Full Text] [Related]
5. Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital.
Advokat C; Dixon D; Schneider J; Comaty JE
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):487-95. PubMed ID: 15093956
[TBL] [Abstract][Full Text] [Related]
6. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three antipsychotics in the emergency psychiatric setting.
Raja M; Azzoni A
Hum Psychopharmacol; 2003 Aug; 18(6):447-52. PubMed ID: 12923822
[TBL] [Abstract][Full Text] [Related]
8. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
[TBL] [Abstract][Full Text] [Related]
9. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
10. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
Sacchetti E; Valsecchi P; Parrinello G;
Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine compared to quetiapine in adolescents with a first psychotic episode.
Arango C; Robles O; Parellada M; Fraguas D; Ruiz-Sancho A; Medina O; Zabala A; Bombín I; Moreno D
Eur Child Adolesc Psychiatry; 2009 Jul; 18(7):418-28. PubMed ID: 19198920
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
Bressan RA; Jones HM; Pilowsky LS
J Psychopharmacol; 2004 Mar; 18(1):124-7. PubMed ID: 15107196
[TBL] [Abstract][Full Text] [Related]
14. [Management of the atypical antipsychotic olanzapine in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German State hospital].
Lutz R; Köhnlein O; Schmauss M; Messer T
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S181-3. PubMed ID: 15570547
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret?
Stahl SM
J Clin Psychiatry; 1999 Jul; 60(7):425-6. PubMed ID: 10453794
[TBL] [Abstract][Full Text] [Related]
16. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Jing Y; Kim E; You M; Pikalov A; Tran QV
J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
[TBL] [Abstract][Full Text] [Related]
17. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
[TBL] [Abstract][Full Text] [Related]
18. Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders.
Migliardi G; D'Arrigo C; Santoro V; Bruno A; Cortese L; Campolo D; Cacciola M; Spina E
Clin Neuropharmacol; 2007; 30(2):107-13. PubMed ID: 17414943
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of antipsychotics in the elderly: a focus on atypicals.
Finkel S
J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S258-65. PubMed ID: 15541166
[No Abstract] [Full Text] [Related]
20. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ
Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
